Opportunity
Quebec SEAO #VB-AAI-20261110
MRI contrast-agent injector for Santé Québec Laurentides
Posted
November 10, 2026
Respond By
November 18, 2026
Identifier
VB-AAI-20261110
NAICS
334510, 423490
Santé Québec Laurentides is seeking suppliers for an MRI contrast-agent injector that meets clinical, safety, and language requirements. - Buyer: Santé Québec Laurentides, within Santé Québec; responses are directed to CISSS des Laurentides. - OEMs and vendors: No manufacturer, OEM, or supplier is named in the opportunity. - Requested product: One type of MRI contrast-agent injector; quantity, model, and part number are not specified. - Key requirements: Programmable, constant-rate injection of contrast agent and saline; adjustable volume, rate, and maximum pressure; contrast-agent temperature maintenance; and features to reduce supply costs and agent use. - Safety and operation: Air-bubble and extravasation detection; safe MRI operation using non-ferromagnetic materials; self-diagnostics with displayed fault reports; French-language controls, screen, and software. - Installation and controls: Suppliers must describe ceiling-suspended, mobile-stand, and examination-table mounting options and installation requirements. An independent control unit for the control room is also required. - Supplier information requested: Product documentation, compatible-supply information, timelines for any pending Health Canada approvals, and Quebec reference sites. - Timing and value: No period of performance, delivery schedule, or estimated contract value is provided.
Description
Santé Québec Laurentides is seeking expressions of interest from suppliers able to provide a contrast-agent injector for magnetic resonance imaging (MRI). The device must support programmable, constant-rate injection of contrast agent and saline, temperature maintenance, supply-use reduction features, advanced safety features, and safe use in an MRI environment. Suppliers must provide written confirmation of supply capability, a completed questionnaire, product documentation, compatible-supplies information, any pending Health Canada approval timelines, and Quebec reference sites. Responses are due by email to CISSS des Laurentides by November 18, 2026, at 12:00 p.m. Quebec Legal Time.